COVID19 news

Petri dish
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.Read more

Software tool will help doctors identify and prevent hospital transmission of SARS-CoV-2

A new software tool developed in Cambridge will help doctors identify where cases of COVID-19 were caused by transmission within a hospital, helping them to prevent further spread of the disease.Read more

alt=""
Age and pre-existing conditions increase risk of stroke among COVID-19 patients

Fourteen out of every 1,000 COVID-19 patients admitted to hospital experience a stroke, a rate that is even higher in older patients and those with severe infection and pre-existing vascular conditions, according to a report.Read more

alt=""
‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection

To better understand how SARS-CoV-2 infects the lungs and causes disease, a team of scientists from the UK and South Korea turned to organoids – ‘mini-organs’ grown in three dimensions to mimic the behaviour of tissue and organs.Read more

alt=""
Supporting research at Cambridge University Hospitals

As the COVID-19 situation develops, research staff at CUH continue our support of COVID-19 research studies, including Urgent Public Health Studies (UPH), while maintaining safe recruitment to existing open studies. Read more

alt=""
Punctured lung affects almost one in a hundred hospitalised COVID-19 patients

As many as one in 100 patients admitted to hospital with COVID-19 develop a pneumothorax – a ‘punctured lung’ according to a study supported by the NIHR Cambridge BRC. Read more

Coronavirus cells
New research shows steroid improves survival of critically ill Covid-19 patients

New research published has been able to show that using the steroid hydrocortisone on patients with severe COVID-19 symptoms improves their recovery.Read more

alt=""
Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

Cambridge University Hospitals has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.Read more

alt=""
TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19

As part of a new trial, a microbe will be used to treat severe COVID-19 in an experimental drug known as EDP1815. Read more

alt=""
Rapid COVID-19 test halves patient waiting times

A new diagnostic test that can diagnose COVID-19 in a hospital setting faster than standard testing methods has been able to halve patients waiting times.Read more

alt=""
Cambridgeshire Trusts join COVID-19 vaccine trial

Three leading NHS Trusts in Cambridgeshire are collaborating on a COVID-19 vaccine trial which has been developed by the University of Oxford.Read more

Prolific study logo
Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.

The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more

Discover more

If you would like more information about NIHR Cambridge BRC, please contact us.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.